BACKGROUND & AIMS: Biliary atresia is an inflammatory, fibrosclerosing neonatal cholangiopathy, characterized by a periductal infiltrate composed of CD4(+) and CD8(+) T cells. The pathogenesis of this disease has been proposed to involve a virus-induced, subsequent autoreactive T cell-mediated bile duct injury. Antigen-specific T-cell immunity involves clonal expansion of T cells expressing similar T-cell receptor (TCR) variable regions of the beta-chain (Vbeta). We hypothesized that the T cells in biliary atresia tissue expressed related TCRs, suggesting that the expansion was in direct response to antigenic stimulation. METHODS: The TCR Vbeta repertoire of T cells from the liver, extrahepatic bile duct remnants, and peripheral blood of biliary atresia and other cholestatic disease controls were characterized by fluorescent-activated cell sorter analysis, and TCR junctional region nucleotide sequencing was performed on expanded TCR Vbeta regions to confirm oligoclonality. RESULTS: FACS analysis revealed Vbeta subset expansions of CD4(+) and CD8(+) T cells from the liver or bile duct remnant in all patients with biliary atresia and only 1 control. The CD4(+) TCR expansions were limited to Vbeta3, -5, -9, and -12 T-cell subsets and the CD8(+) TCR Vbeta expansions were predominantly Vbeta20. Each Vbeta subset expansion was composed of oligoclonal populations of T cells. CONCLUSIONS: Biliary atresia is associated with oligoclonal expansions of CD4(+) and CD8(+) T cells within liver and extrahepatic bile duct remnant tissues, indicating the presence of activated T cells reacting to specific antigenic stimulation. Future studies entail identifying the specific antigen(s) responsible for T-cell activation and bile duct injury.
BACKGROUND & AIMS:Biliary atresia is an inflammatory, fibrosclerosing neonatal cholangiopathy, characterized by a periductal infiltrate composed of CD4(+) and CD8(+) T cells. The pathogenesis of this disease has been proposed to involve a virus-induced, subsequent autoreactive T cell-mediated bile duct injury. Antigen-specific T-cell immunity involves clonal expansion of T cells expressing similar T-cell receptor (TCR) variable regions of the beta-chain (Vbeta). We hypothesized that the T cells in biliary atresia tissue expressed related TCRs, suggesting that the expansion was in direct response to antigenic stimulation. METHODS: The TCR Vbeta repertoire of T cells from the liver, extrahepatic bile duct remnants, and peripheral blood of biliary atresia and other cholestatic disease controls were characterized by fluorescent-activated cell sorter analysis, and TCR junctional region nucleotide sequencing was performed on expanded TCR Vbeta regions to confirm oligoclonality. RESULTS: FACS analysis revealed Vbeta subset expansions of CD4(+) and CD8(+) T cells from the liver or bile duct remnant in all patients with biliary atresia and only 1 control. The CD4(+) TCR expansions were limited to Vbeta3, -5, -9, and -12 T-cell subsets and the CD8(+) TCR Vbeta expansions were predominantly Vbeta20. Each Vbeta subset expansion was composed of oligoclonal populations of T cells. CONCLUSIONS:Biliary atresia is associated with oligoclonal expansions of CD4(+) and CD8(+) T cells within liver and extrahepatic bile duct remnant tissues, indicating the presence of activated T cells reacting to specific antigenic stimulation. Future studies entail identifying the specific antigen(s) responsible for T-cell activation and bile duct injury.
Authors: M Riepenhoff-Talty; V Gouvea; M J Evans; L Svensson; E Hoffenberg; R J Sokol; I Uhnoo; S J Greenberg; K Schäkel; G Zhaori; J Fitzgerald; S Chong; M el-Yousef; A Nemeth; M Brown; D Piccoli; J Hyams; D Ruffin; T Rossi Journal: J Infect Dis Date: 1996-07 Impact factor: 5.226
Authors: Cara L Mack; Rebecca M Tucker; Brandy R Lu; Ronald J Sokol; Andrew P Fontenot; Yoshiyuki Ueno; Ronald G Gill Journal: Hepatology Date: 2006-11 Impact factor: 17.425
Authors: Andrew K Sullivan; Philip L Simonian; Michael T Falta; John D Mitchell; Gregory P Cosgrove; Kevin K Brown; Brian L Kotzin; Norbert F Voelkel; Andrew P Fontenot Journal: Am J Respir Crit Care Med Date: 2005-06-03 Impact factor: 21.405
Authors: K L Tyler; R J Sokol; S M Oberhaus; M Le; F M Karrer; M R Narkewicz; R W Tyson; J R Murphy; R Low; W R Brown Journal: Hepatology Date: 1998-06 Impact factor: 17.425
Authors: T P Prindiville; M C Cantrell; T Matsumoto; W R Brown; A A Ansari; B L Kotzin; M E Gershwin Journal: J Autoimmun Date: 1996-04 Impact factor: 7.094
Authors: Alexander G Miethke; Vijay Saxena; Pranavkumar Shivakumar; Gregg E Sabla; Julia Simmons; Claire A Chougnet Journal: J Hepatol Date: 2010-03-05 Impact factor: 25.083